Linked Data API

Show Search Form

Search Results

1718156
registered interest false more like this
date less than 2024-05-14more like thismore than 2024-05-14
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Prices more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the impact of the NHS England uniform pricing policy on patients' access to innovative medicines. more like this
tabling member printed
Lord Warner more like this
uin HL4654 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-05-21more like thismore than 2024-05-21
answer text <p>NHS England has successfully secured patient access to a number of innovative medicines under its policy of uniform pricing. European industry data from April 2023 showed that for every four treatments available in Europe, there is an additional medicine available in England, and a quarter more cancer drugs available in England compared to the European average.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-05-21T12:26:39.693Zmore like thismore than 2024-05-21T12:26:39.693Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
1732
label Biography information for Lord Warner more like this